VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including… Read More
VANCOUVER, BC. — NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that President… Read More
Three Simon Fraser University (SFU) scholars have been named to the Royal Society of Canada (RSC)—two of them as Fellows and one as a member of the society’s College of… Read More
An innovative program breaks ground to provide wrap-around services for individuals living with HIV, hepatitis C and other comorbidities. Opportunities to connect with the broader community are not always available… Read More
Industry veteran with deep commercial experience joins to lead the next stage of growth and development Dr. Philip Toleikis will serve as Chief Technology Officer Sernova to host investor calls… Read More
